Allegro Inks Second Asian Alliance For Luminate
This article was originally published in PharmAsia News
Executive Summary
Allegro has secured a second Asian partner for its novel integrin peptide therapy for ophthalmic disorders, linking with Hanmi for the Korean and Chinese markets.